Carisma Therapeutics Share Price (NASDAQ: CARM)
$0.21
Last updated on
Check the interactive Carisma Therapeutics Stock chart to analyse performance
Carisma Therapeutics stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$0.21Today's High:$0.23
0.0%
Downside
Day's Volatility :9.13%
Upside
9.13%
- 52 Weeks Low:$0.1452 Weeks High:$1.27
32.52%
Downside
52 Weeks Volatility :88.84%
Upside
83.46%
Carisma Therapeutics Stock Returns
Carisma Therapeutics Inc Key Stats
Check Carisma Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Carisma Therapeutics Stock including INR - Dollar returns
The Carisma Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Carisma Therapeutics investment value today
Current value as on today
₹24,910
Returns
Returns from Carisma Therapeutics Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Carisma Therapeutics Stock
Analyst Recommendation on Carisma Therapeutics Stock
Buy
91%Buy
8%Hold
0%Sell
Based on 12 Wall street analysts offering stock ratings for Carisma Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Carisma Therapeutics Share Price Target
What analysts predicted
Upside of 376.19%
Target:
$1.00
Current:
$0.21
Carisma Therapeutics share price target is $1.00, a slight Upside of 376.19% compared to current price of $0.21 as per analysts' prediction.
Carisma Therapeutics Stock Insights
Price Movement
In the last 7 days, CARM stock has moved down by -7.2%Increasing Revenue
Revenue is up for the last 3 quarters, 3.38M → 3.72M (in $), with an average increase of 4.7% per quarterDecreasing Net Profit
Netprofit is down for the last 2 quarters, -9.26M → -9.77M (in $), with an average decrease of 5.5% per quarterCARM vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 149.4%Price to Sales
ForCARM every $1 of sales, investors are willing to pay $0.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Carisma Therapeutics Technicals Summary
Sell
Neutral
Buy
Carisma Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Carisma Therapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -31.99% | -45.3% | -78.1% | -94.03% | -94.03% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -0.69 | -3.63 | -0.86 | NA | -1.1 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $9.5M | -94.03% | NA | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Carisma Therapeutics Inc
Key Management of Carisma Therapeutics Inc
Important FAQs about investing in CARM Stock from India :
What is Carisma Therapeutics share price today?
Carisma Therapeutics share price today is $0.21 as on at the close of the market. Carisma Therapeutics share today touched a day high of $0.23 and a low of $0.21.
What is the 52 week high and 52 week low for Carisma Therapeutics share?
Carisma Therapeutics share touched a 52 week high of $1.27 and a 52 week low of $0.14. Carisma Therapeutics stock price today i.e. is closed at $0.21, lower by 83.46% versus the 52 week high.
How to invest in Carisma Therapeutics Stock (CARM) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Carisma Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Carisma Therapeutics Shares that will get you 7.1429 shares as per Carisma Therapeutics share price of $0.21 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Carisma Therapeutics Stock (CARM) from India?
Indian investors can start investing in Carisma Therapeutics (CARM) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Carisma Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Carisma Therapeutics share’s latest price of $0.21 as on August 30, 2025 at 1:29 am IST, you will get 47.6190 shares of Carisma Therapeutics. Learn more about
fractional shares .
What are the returns that Carisma Therapeutics has given to Indian investors in the last 5 years?
Carisma Therapeutics stock has given -94.03% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
- Cambria Value And Momentum Etf
$32.55
+0.25%